Spots Global Cancer Trial Database for Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer
Official Title: A Phase II Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Locally Advanced or Metastatic Breast Cancer
Study ID: NCT00669565
Conditions
Interventions
Study Description
Brief Summary: This is a phase II, multicenter, single-arm, open-label safety and efficacy study of bavituximab in combination with carboplatin plus paclitaxel in patients with locally advanced or metastatic breast cancer.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Rajalakshmi Multispecialty Hospital, Bangalore, , India
Bangalore Institute of Oncology, Banglore, , India
Apollo Specialty Hospitals, Chennai, , India
Nizam's Institute of Medical Sciences, Hyderabaad, , India
Regional Cancer Center, Kerala, , India
Medical College Hospital, Kolkata, , India
Bharath Hospital and Institite of Oncology, Mysore, , India
Curie Manavata Cancer Center, Nashik, , India
Ruby Hall Clinic, Pune, , India
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
